<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Richard Lehman&#8217;s journal blog, 27 April 2009</title>
	<atom:link href="http://blogs.bmj.com/bmj/2009/04/27/richard-lehmans-journal-blog-27-april-2009/feed/" rel="self" type="application/rss+xml" />
	<link>http://blogs.bmj.com/bmj/2009/04/27/richard-lehmans-journal-blog-27-april-2009/</link>
	<description>Just another blogs.bmj.com weblog</description>
	<pubDate>Tue, 24 Nov 2009 06:11:22 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
		<item>
		<title>By: Sergio Stagnaro</title>
		<link>http://blogs.bmj.com/bmj/2009/04/27/richard-lehmans-journal-blog-27-april-2009/#comment-4273</link>
		<dc:creator>Sergio Stagnaro</dc:creator>
		<pubDate>Thu, 07 May 2009 20:13:12 +0000</pubDate>
		<guid isPermaLink="false">http://blogs.bmj.com/bmj/?p=665#comment-4273</guid>
		<description>Despite Trish Groves's statements, all physicians agree with, diabetes, hypertension, cancer are growing epidaemics in western countries! Something is wrong in what has been done until now (see in IAS official website athero.org, my two Comentaries...</description>
		<content:encoded><![CDATA[<p>Despite Trish Groves&#8217;s statements, all physicians agree with, diabetes, hypertension, cancer are growing epidaemics in western countries! Something is wrong in what has been done until now (see in IAS official website athero.org, my two Comentaries&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Trish Groves</title>
		<link>http://blogs.bmj.com/bmj/2009/04/27/richard-lehmans-journal-blog-27-april-2009/#comment-4210</link>
		<dc:creator>Trish Groves</dc:creator>
		<pubDate>Mon, 27 Apr 2009 21:51:44 +0000</pubDate>
		<guid isPermaLink="false">http://blogs.bmj.com/bmj/?p=665#comment-4210</guid>
		<description>It's the authors who are opting for BMJ pico for their original research articles, not us. If authors wish to be "piconeers" we provide them with the appropriate basic template for their study's design, and they write their own BMJ pico. 
For readers who may wonder what we're talking about, here's a bit more explanation. Each accepted BMJ research article is published fully, with open access and no word limit, on bmj.com - that's the definitive publication that is cited and indexed and is not superceded by the subsequent print version.
For the past decade we've been abridging all original BMJ research articles so that they each cover about 3 pages in the print BMJ, using a process we've called ELPS (electronic long, paper short). This abridging is meant to help print readers to keep up with research while avoiding information overload. But some readers have been confused by these abridged versions, assuming them to be the full papers and thinking that the BMJ must have a very strict word limit for research. 
BMJ pico is a new way to abridge research papers for the print BMJ after their full publication on bmj.com, and it's essentially an evidence abstract covering 1 page. Because authors write these they gain control of the abridging without too much extra work; yet, because they're using templates, this doesn't entail much extra work.  
There's no way a BMJ pico could be confused with a full paper, and yet it gives the key information about the research question, the findings, the study design, possible biases and other limitations, competing interests, and funding. It usually includes a small but informative table or figure too. 
At the moment we're piloting BMJ pico, and that's why the print BMJ currently carries a mix of the two abridged formats.</description>
		<content:encoded><![CDATA[<p>It&#8217;s the authors who are opting for BMJ pico for their original research articles, not us. If authors wish to be &#8220;piconeers&#8221; we provide them with the appropriate basic template for their study&#8217;s design, and they write their own BMJ pico.<br />
For readers who may wonder what we&#8217;re talking about, here&#8217;s a bit more explanation. Each accepted BMJ research article is published fully, with open access and no word limit, on bmj.com - that&#8217;s the definitive publication that is cited and indexed and is not superceded by the subsequent print version.<br />
For the past decade we&#8217;ve been abridging all original BMJ research articles so that they each cover about 3 pages in the print BMJ, using a process we&#8217;ve called ELPS (electronic long, paper short). This abridging is meant to help print readers to keep up with research while avoiding information overload. But some readers have been confused by these abridged versions, assuming them to be the full papers and thinking that the BMJ must have a very strict word limit for research.<br />
BMJ pico is a new way to abridge research papers for the print BMJ after their full publication on bmj.com, and it&#8217;s essentially an evidence abstract covering 1 page. Because authors write these they gain control of the abridging without too much extra work; yet, because they&#8217;re using templates, this doesn&#8217;t entail much extra work.<br />
There&#8217;s no way a BMJ pico could be confused with a full paper, and yet it gives the key information about the research question, the findings, the study design, possible biases and other limitations, competing interests, and funding. It usually includes a small but informative table or figure too.<br />
At the moment we&#8217;re piloting BMJ pico, and that&#8217;s why the print BMJ currently carries a mix of the two abridged formats.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
